In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lantos Technologies Inc.

Latest From Lantos Technologies Inc.

Life Science Start-Ups: Venture Funding, April 2014

Derived from Strategic Transactions, a fully searchable premium source for tracking life sciences deal activity, the Venture Funding column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced February through March 2014.

BioPharmaceutical Medical Device

Emergings In Brief (10/2010)

Brief profiles of these recently formed companies: Dermadis, Lantos Technologies, Pulsar Vascular, TheraVasc.

Selected Start-Ups (10/2010)

In Vivo briefly describes these recently founded companies: Annovation BioPharma, BioMatrx, Dermadis, Lantos Technologies, Pulsar Vascular and TheraVasc.
See All

Company Information

  • Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
  • Therapeutic Areas
  • Otolaryngology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Lantos Technologies Inc.
  • Senior Management
  • Jeffrey C Leathe, Chmn. & CEO
    Gary St. Pierre, VP, CFO
    Lora Allemeier, Chief Development Officer
    Jennifer M Rossi, PhD, VP, Mktg.
  • Contact Info
  • Lantos Technologies Inc.
    Phone: (617) 500-9800
    201 Edgewater Dr.
    Suite 241
    Wakefield, MA 01880